Related by context. Frequent words. (Click for all words.) 73 refractory chronic lymphocytic 69 liposomal formulation 69 Meets Primary Endpoint 68 Inc. Nasdaq IMGN 68 Initiates Phase II 68 forodesine 68 Nasdaq VRTX 67 histone deacetylase HDAC inhibitor 66 Phase IIb clinical trials 66 Initiate Phase 65 Panzem R 65 Receives Orphan Drug Designation 65 recurrent glioblastoma multiforme 65 polymerase inhibitor 65 Hepatitis C HCV 65 ongoing Phase 1b 65 Epratuzumab 65 Genasense ® oblimersen 65 HCV protease inhibitor 65 Fast Track Status 65 ThermoDox R 65 multi kinase inhibitor 65 Nasdaq OSIP 64 Pivotal Phase III 64 Presents Positive 64 cutaneous T 64 relapsed multiple myeloma 64 KNS # 64 Ixempra 64 metastatic castration resistant 64 FDA Accepts 64 fibrosis IPF 64 GRNVAC1 64 TTR amyloidosis 64 Pegintron 64 Cethromycin 64 REGN# 64 Factor VIIa 64 HGS ETR2 63 nitazoxanide 63 MEK inhibitor 63 R sorafenib tablets 63 virus HCV infection 63 Plicera 63 INCB# [001] 63 elotuzumab 63 gastrointestinal stromal tumors GIST 63 Metabasis Therapeutics Inc. 63 supplemental biologics 63 proteasome inhibitor 63 ZALBIN 63 GVAX R 63 systemically administered 63 Drug Candidate 63 PEG SN# 63 Tarvacin TM 63 anidulafungin 62 gets USFDA nod 62 relapsed refractory multiple myeloma 62 Clevudine 62 BiTE R 62 CCR5 antagonist 62 neuraminidase inhibitor 62 Application MAA 62 multiple myeloma MM 62 targeting CD# 62 Paraplatin 62 ACHN 62 Aurexis 62 Chronic Hepatitis C 62 phase Ib 62 complicated intra abdominal 62 PRT# 62 fumarate 62 ImmunoCellular Therapeutics 62 metastatic hormone refractory 62 Alinia 62 Recombinant Human 62 cidofovir 62 AEG# 62 AEGR 62 elvucitabine 62 CRTX 62 JAK inhibitor 62 Boceprevir 61 SAR# [004] 61 Golimumab 61 metastatic castrate resistant 61 leukemia CLL 61 CDP# 61 Edurant 61 immune modulating 61 ganetespib 61 Aliskiren 61 Epivir 61 Daclizumab 61 ALN TTR 61 Prulifloxacin 61 Nasdaq ENZN 61 oral deforolimus 61 phase IIb clinical